Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2015

Jun 9, 2015

30718_dirs_2015-06-09_e3e4b3c8-85f0-4764-9f27-75797d2be43e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2015-06-08

Reporting Person: STEER RANDOLPH C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-06-08 Common Stock S 1000 $99.3858 Disposed 1000 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $91.78 2024-10-30 Common Stock (4000) 4000 Direct
Stock Option $87.39 2023-10-30 Common Stock (4000) 4000 Direct
Stock Option $66.9 2022-10-24 Common Stock (5000) 5000 Direct
Stock Option $70.35 2021-10-26 Common Stock (5000) 5000 Direct